Found: 9
Select item for more details and to access through your institution.
Rab25 promotes erlotinib resistance by activating the β1 integrin/AKT/β‐catenin pathway in NSCLC.
- Published in:
- Cell Proliferation, 2019, v. 52, n. 3, p. N.PAG, doi. 10.1111/cpr.12592
- By:
- Publication type:
- Article
Neoantigen Tracking: Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer (Adv. Sci. 9/2020).
- Published in:
- Advanced Science, 2020, v. 7, n. 9, p. 1, doi. 10.1002/advs.201903410
- By:
- Publication type:
- Article
Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer.
- Published in:
- Advanced Science, 2020, v. 7, n. 9, p. 1, doi. 10.1002/advs.201903410
- By:
- Publication type:
- Article
Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study.
- Published in:
- Oncology Letters, 2019, v. 17, n. 6, p. 5590
- By:
- Publication type:
- Article
Concurrent EGFR‐TKI and Thoracic Radiotherapy as First‐Line Treatment for Stage IV Non‐Small Cell Lung Cancer Harboring EGFR Active Mutations.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. 1031, doi. 10.1634/theoncologist.2019-0285
- By:
- Publication type:
- Article
Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population‐based analysis.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 4, p. 751, doi. 10.1111/1759-7714.12993
- By:
- Publication type:
- Article
The Evolution of BRAF Activation in Non-Small-Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.882940
- By:
- Publication type:
- Article
Hyperprogressive Disease In Cervical Small Cell Carcinoma Treated By Immune Checkpoint Inhibitor.
- Published in:
- OncoTargets & Therapy, 2019, v. 12, p. 8873, doi. 10.2147/OTT.S213436
- By:
- Publication type:
- Article
Novel Biomarkers of Dynamic Blood PD-L1 Expression for Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.665133
- By:
- Publication type:
- Article